al Karawi M A, el-Shiekh Mohamed A R, Yasawy M I
Gastroenterology Division, Armed Forces Hospital, Riyadh, Kingdom of Saudi Arabia.
Hepatogastroenterology. 1990 Jun;37(3):327-31.
Over the last decade substantial improvements have been made in the diagnosis and management of hydatid disease. New diagnostic tests, imaging procedures including ultrasonography, computerized tomography, magnetic resonance and ERCP. Until recently the only definitive treatment for hydatid disease has been surgery, which carries high morbidity, mortality and recurrence. Advances in drug therapy has been influenced by the introduction of Albendazole. In our own study, Albendazole was administered to 22 patients with hydatid disease of the liver, and encouraging results were achieved in most of the patients. Another recent improvement has been the introduction of a non-surgical endoscopic method for the management of biliary and liver echinococcus. In 1985 we published the first report on the use of this procedure. The fourth recent aspect of treatment is the percutaneous aspiration and drainage of hydatid cyst of the liver. These recent developments, used either alone or in combination, are, we believe, good potential alternatives to operative surgery that carry a smaller incidence of complications, morbidity and mortality.
在过去十年中，包虫病的诊断和管理有了实质性进展。新的诊断测试、成像程序，包括超声检查、计算机断层扫描、磁共振成像和内镜逆行胰胆管造影术。直到最近，包虫病唯一的确定性治疗方法一直是手术，但手术具有高发病率、死亡率和复发率。药物治疗的进展受到阿苯达唑引入的影响。在我们自己的研究中，对22例肝包虫病患者给予了阿苯达唑治疗，大多数患者取得了令人鼓舞的结果。最近的另一项进展是引入了一种用于治疗胆道和肝棘球蚴病的非手术内镜方法。1985年我们发表了关于使用该程序的第一份报告。治疗的第四个近期方面是经皮穿刺抽吸和引流肝包虫囊肿。我们认为，这些最近的进展单独或联合使用，是手术的良好潜在替代方法，并发症、发病率和死亡率的发生率较低。
